Diabetologia

, Volume 61, Issue 2, pp 504–505 | Cite as

Correction to: Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans

  • Rebecca K. C. Loh
  • Melissa F. Formosa
  • Nina Eikelis
  • David A. Bertovic
  • Mitchell J. Anderson
  • Shane A. Barwood
  • Shane Nanayakkara
  • Neale D. Cohen
  • Andre La Gerche
  • Anne T. Reutens
  • Kenneth S. Yap
  • Thomas W. Barber
  • Gavin W. Lambert
  • Martin H. Cherk
  • Stephen J. Duffy
  • Bronwyn A. Kingwell
  • Andrew L. Carey
Correction
  • 3.1k Downloads

Correction to: Diabetologia

DOI:   https://doi.org/10.1007/s00125-017-4479-9

The baseline insulin data given in Table 1 for the placebo group were incorrectly reported as 51 ± 10 pmol/l instead of 48 ± 10 pmol/l. This mistake also impacts on data reported in Table 4. The authors also note an error in the reported change in noradrenaline levels, from pre- to post-pioglitazone treatment (Table 4). The relevant rows from Tables 1 and 4 are reproduced here, with corrected data shown in bold. These corrections do not change the statistical significance of any comparison.
Table 1

 Participant baseline characteristics

Characteristic

Placebo

Pioglitazone

p value

N

7

7

 

Fasting plasma hormones, metabolites and lipids

   

  Insulin (pmol/l)

48 ± 10

36 ± 4

0.31

Data are means ± SEM

Table 4

 Basal, fasting hormones, metabolites and lipids before and after the intervention

Variable

Placebo (n=7)

Pioglitazone (n=7)

 

Pre-intervention

Post-intervention

Change

Pre-intervention

Post-intervention

Change

Noradrenaline (pmol/l)

1322 ± 186

1325 ± 355

4 ± 374

1449 ± 219

1293 ± 418

156 ± 391

Insulin (pmol/l)

48 ± 10

43 ± 3

−4.2 ± 8.0

36 ± 4

38 ± 6

1.3 ± 3.9

Data are means ± SEM

Change represents the difference between pre- and post-intervention for each group (Post−Pre)

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2017

Authors and Affiliations

  • Rebecca K. C. Loh
    • 1
  • Melissa F. Formosa
    • 1
  • Nina Eikelis
    • 2
    • 3
  • David A. Bertovic
    • 1
  • Mitchell J. Anderson
    • 1
    • 4
  • Shane A. Barwood
    • 4
  • Shane Nanayakkara
    • 5
  • Neale D. Cohen
    • 6
  • Andre La Gerche
    • 7
  • Anne T. Reutens
    • 6
  • Kenneth S. Yap
    • 8
    • 9
  • Thomas W. Barber
    • 8
    • 9
  • Gavin W. Lambert
    • 2
    • 3
  • Martin H. Cherk
    • 8
    • 9
  • Stephen J. Duffy
    • 5
  • Bronwyn A. Kingwell
    • 1
  • Andrew L. Carey
    • 1
  1. 1.Metabolic and Vascular Physiology LaboratoryBaker Heart and Diabetes InstituteMelbourneAustralia
  2. 2.Human Neurotransmitters LaboratoryBaker Heart and Diabetes InstituteMelbourneAustralia
  3. 3.Iverson Health Innovation Research Institute, Swinburne Institute of TechnologyMelbourneAustralia
  4. 4.Melbourne Orthopaedic GroupWindsorAustralia
  5. 5.Department of Cardiovascular MedicineAlfred HospitalMelbourneAustralia
  6. 6.Baker Heart and Diabetes InstituteMelbourneAustralia
  7. 7.Sports Cardiology LaboratoryBaker Heart and Diabetes InstituteMelbourneAustralia
  8. 8.The Department of Nuclear Medicine and PET, Alfred HealthMelbourneAustralia
  9. 9.Department of MedicineMonash University, Alfred Hospital CampusMelbourneAustralia

Personalised recommendations